Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gastl

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Immunology|November 1, 1991
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma)W E Aulitzky, H Grosse-Wilde, U Westhoff, et al.
Lancet (London, England)|October 13, 2001
Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donorsD Nachbaur, H Bonatti, W Oberaigner, et al.
Immunobiology|June 1, 1990
Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alphaW E Aulitzky, W K Aulitzky, J Frick, et al.
Blood|July 1, 1984
Human large granular lymphocytes and their relationship to natural killer cell activity in various disease statesG Gastl, D Niederwieser, C Marth, et al.
British Journal of Cancer|February 20, 2003
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survivalG Spizzo, G Gastl, D Wolf, et al.
Cancer|January 28, 1999
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant diseaseA Kraft, K Weindel, A Ochs, et al.
Transplantation|October 1, 1990
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messagesD Niederwieser, M Herold, W Woloszczuk, et al.
Annals of Hematology|September 25, 2003
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solutionC Lass-Flörl, E Gunsilius, G Gastl, et al.
Acta Medica Austriaca|January 1, 1985
[Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon]W Aulitzky, G Gastl, J Troppmair, et al.
Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Immunology|November 1, 1991
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma)W E Aulitzky, H Grosse-Wilde, U Westhoff, et al.
Lancet (London, England)|October 13, 2001
Survival after bone marrow transplantation from cytomegalovirus seropositive sibling donorsD Nachbaur, H Bonatti, W Oberaigner, et al.
Immunobiology|June 1, 1990
Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alphaW E Aulitzky, W K Aulitzky, J Frick, et al.
Blood|July 1, 1984
Human large granular lymphocytes and their relationship to natural killer cell activity in various disease statesG Gastl, D Niederwieser, C Marth, et al.
British Journal of Cancer|February 20, 2003
Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survivalG Spizzo, G Gastl, D Wolf, et al.
Cancer|January 28, 1999
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant diseaseA Kraft, K Weindel, A Ochs, et al.
Transplantation|October 1, 1990
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messagesD Niederwieser, M Herold, W Woloszczuk, et al.
Annals of Hematology|September 25, 2003
Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solutionC Lass-Flörl, E Gunsilius, G Gastl, et al.
Acta Medica Austriaca|January 1, 1985
[Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon]W Aulitzky, G Gastl, J Troppmair, et al.
Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.
Pageof 14